Ginsenoside Rc Ameliorates Endothelial Insulin Resistance via Upregulation of Angiotensin-Converting Enzyme 2.

Front Pharmacol · 2021 · PMC7940763 · PMID 33708129

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

Meanwhile, the insulin level in db/db mice treated with ginsenoside Rc presented a descending trend, which failed to reach significance ( Figure 11B ).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.